Sagimet Biosciences Inc (SGMT)
4.09
+0.19
(+4.87%)
USD |
NASDAQ |
May 01, 16:00
4.10
+0.01
(+0.24%)
After-Hours: 20:00
Sagimet Biosciences Cash and Short Term Investments (Quarterly): 94.90M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 94.90M |
| September 30, 2023 | 101.84M |
| June 30, 2023 | 18.51M |
| Date | Value |
|---|---|
| March 31, 2023 | 25.25M |
| December 31, 2022 | 32.34M |
| March 31, 2021 | 74.94M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
18.51M
Minimum
Jun 2023
101.84M
Maximum
Sep 2023
57.96M
Average
53.64M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 634.13M |
| 89bio Inc | 578.87M |
| Viking Therapeutics Inc | 962.98M |
| Akero Therapeutics Inc | 550.01M |
| Arrowhead Pharmaceuticals Inc | 220.28M |